Company
GlyCardial Diagnostics
- Business model
- B2B
Record updated 28 September 2026
About
GlyCardial Diagnostics is a spin-off company from the IR-Hospital de la Santa Creu i Sant Pau and the Spanish National Research Council ( CSIC ). The company is focused on the development of a novel in vitro diagnostic test for myocardial ischemia. The technology is based on the detection of Apo J-Glyc in blood as a biomarker for the early diagnosis of cardiac ischemia and the prediction of patient’s evolution after an ischemic event. - Inactive